» Articles » PMID: 25483535

Changes in the Epidemiology of Hepatitis A Outbreaks 13 Years After the Introduction of a Mass Vaccination Program

Abstract

A hepatitis A+B vaccine vaccination program of 12-year-olds was introduced in Catalonia in 1998. The aim of this study was to investigate the evolution of hepatitis A outbreaks in Catalonia and estimate the preventable fraction of cases associated with outbreaks as a measure of the impact of the vaccination program. Hepatitis A outbreaks reported to the Health Department between 1991 and 2012 were analyzed. The incidence rates of outbreaks, outbreak-associated cases and hospitalizations were calculated. The preventable fraction (PF) and 95% confidence intervals (CI) were estimated for the whole study period (pre-vaccination and post-vaccination) and the post-vaccination period.   One-hundred-eight (108) outbreaks (rate of 2.21 per 10(6) persons-year) were reported in the pre-vaccination period and 258 outbreaks (rate of 2.82 per 10(6) persons-year) in the post-vaccination period. The rate of cases associated with outbreaks was 1.52 per 10(5) persons-year in the pre-vaccination period and 1.28 per 10(5) persons-year in the post-vaccination period. Hospitalization rates were 0.08 and 0.75 per 10(6) persons-year, respectively. The number of person-to-person outbreaks whose index case was a school contact decreased in the post-vaccination period (aOR 2.72; 95%CI 1.35-5.48), but outbreaks whose index case was a man who has sex with men (MSM) or an immigrant increased. The PF of all outbreak-associated cases was 6.46% (95%CI 3.11-9.82) and the highest PF was in the 15-24 years age group (42.53%; 95%CI 29.30-55.75). In the 0-4 years age group, the PF was 18.35% (95%CI 9.59-27.11), suggesting a protective herd effect in unvaccinated subjects. Vaccination of immigrants traveling to endemic countries and MSM should be reinforced.

Citing Articles

Vaccination status and hepatitis A immunity in children: insights from a large-scale study in Turkey.

Yigit M, Kalayci F BMC Infect Dis. 2025; 25(1):61.

PMID: 39810097 PMC: 11734540. DOI: 10.1186/s12879-025-10458-9.


Hepatitis A vaccination and its immunological and epidemiological long-term effects - a review of the evidence.

Herzog C, Van Herck K, Van Damme P Hum Vaccin Immunother. 2020; 17(5):1496-1519.

PMID: 33325760 PMC: 8078665. DOI: 10.1080/21645515.2020.1819742.


Epidemiology of hepatitis A in Greece in the last decade: management of reported cases and outbreaks and lessons learned.

Mellou K, Chrysostomou A, Sideroglou T, Kyritsi M, Georgakopoulou T, Tsiodras S Epidemiol Infect. 2020; 148:e58.

PMID: 32052723 PMC: 7078582. DOI: 10.1017/S0950268820000382.


Human immunodeficiency virus and liver disease: A comprehensive update.

Sherman K, Peters M, Thomas D Hepatol Commun. 2019; 1(10):987-1001.

PMID: 30838978 PMC: 5721407. DOI: 10.1002/hep4.1112.


Persistence of antibodies 20 y after vaccination with a combined hepatitis A and B vaccine.

Van Damme P, Leroux-Roels G, Suryakiran P, Folschweiller N, Van Der Meeren O Hum Vaccin Immunother. 2017; 13(5):972-980.

PMID: 28281907 PMC: 5443376. DOI: 10.1080/21645515.2016.1274473.


References
1.
Tortajada C, de Olalla P, Pinto R, Bosch A, Cayla J . Outbreak of hepatitis A among men who have sex with men in Barcelona, Spain, September 2008-March 2009. Euro Surveill. 2009; 14(15). View

2.
Motte A, Blanc J, Minodier P, Colson P . Acute hepatitis A in a pregnant woman at delivery. Int J Infect Dis. 2008; 13(2):e49-51. DOI: 10.1016/j.ijid.2008.06.009. View

3.
Broman M, Jokinen S, Kuusi M, Lappalainen M, Roivainen M, Liitsola K . Epidemiology of hepatitis A in Finland in 1990-2007. J Med Virol. 2010; 82(6):934-41. DOI: 10.1002/jmv.21759. View

4.
Pini A, Tomasoni L, Cristini G, Puoti M, Matteelli A, Carosi G . Hepatitis A in men having sex with men (MSMs) in northern Italy. Infez Med. 2010; 18(2):113-4. View

5.
Arteaga-Rodriguez A, Carrasco-Garrido P, Lopez de Andres A, de Miguel A, Santos J, Jimenez-Garcia R . Changes in the epidemiology of hepatitis A in Spain (2005–2008): trends of acute hepatitis A hospitalizations, comorbidities, and costs associated with the hospitalization. Eur J Gastroenterol Hepatol. 2010; 22(11):1284-9. DOI: 10.1097/meg.0b013e32833bce39. View